CONSTELLIUM SE (CSTM) reporting calendar
CONSTELLIUM SE files periodic reports with the SEC as CSTM on NYSE. Atlas tracks 17 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 19 Jul 2026 – 5 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 29 Apr 2026
- Reports on record
- 17
How this window is derived. Derived from this issuer's own filing history: 6 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 29 Apr 2026 | 29 days | 0001563411-26-000155 |
| 10-K | 31 Dec 2025 | 25 Feb 2026 | 56 days | 0001563411-26-000057 |
| 10-Q | 30 Sep 2025 | 29 Oct 2025 | 29 days | 0001563411-25-000028 |
| 10-Q | 30 Jun 2025 | 31 Jul 2025 | 31 days | 0001563411-25-000019 |
| 10-Q | 31 Mar 2025 | 30 Apr 2025 | 30 days | 0001563411-25-000011 |
| 10-K | 31 Dec 2024 | 28 Feb 2025 | 59 days | 0001563411-25-000005 |
| 20-F | 31 Dec 2023 | 18 Mar 2024 | 78 days | 0001563411-24-000006 |
| 20-F | 31 Dec 2022 | 14 Mar 2023 | 73 days | 0001563411-23-000005 |
| 20-F | 31 Dec 2021 | 14 Mar 2022 | 73 days | 0001563411-22-000005 |
| 20-F | 31 Dec 2020 | 17 Mar 2021 | 76 days | 0001563411-21-000006 |
| 20-F | 31 Dec 2019 | 9 Mar 2020 | 69 days | 0001563411-20-000006 |
| 20-F | 31 Dec 2018 | 11 Mar 2019 | 70 days | 0001193125-19-070927 |
| 20-F | 31 Dec 2017 | 12 Mar 2018 | 71 days | 0001193125-18-079483 |
| 20-F | 31 Dec 2016 | 21 Mar 2017 | 80 days | 0001193125-17-090611 |
| 20-F | 31 Dec 2015 | 18 Apr 2016 | 109 days | 0001193125-16-545056 |
| 20-F | 31 Dec 2014 | 24 Apr 2015 | 114 days | 0001193125-15-146764 |
| 20-F | 31 Dec 2013 | 22 Apr 2014 | 112 days | 0001193125-14-152916 |
Source: SEC EDGAR company submissions for CIK 0001563411. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.